AlphaCentric Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

AlphaCentric Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-175	Closed	-$24K	–	243
2020 Q3	$24K	Buy	+175	New	+$18.6K	0.01%	139

AlphaCentric Advisors's MYOK Position: Q4 2020 in Review

AlphaCentric Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 175 shares — an estimated $24K sold.

AlphaCentric Advisors first reported a position in MYOK in Q3 2020 and held it in 1 quarter. The position peaked at $24K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

AlphaCentric Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
AlphaCentric Advisors sold 175 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $24K.
AlphaCentric Advisors first reported a position in MyoKardia, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
AlphaCentric Advisors's MyoKardia, Inc. Common Stock position peaked at $24K in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on AlphaCentric Advisors's 13F filing for Q4 2020, filed 11 Mar 2022.